← Back to CSTL

Castle Biosciences, Inc. - Common stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 30/07/2026Mar 2026Filed 30/07/2026Sep 2025Filed 03/11/2025Jun 2025Filed 30/07/2026Mar 2025Filed 30/07/2026Sep 2024Filed 03/11/2025Jun 2024Filed 03/11/2025Mar 2024Filed 03/11/2025
$104$84$83$86$88$86$87$73
−$2.1−$15−$0.5$4.5−$26$2.3$8.9−$2.5
−$0.07−$0.49−$0.02$0.15−$0.90$0.08$0.31−$0.09
3030293029292927

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.